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Trypanosoma cruzi, the causative agent of Chagas dis-
ease, infects 10–18 million people and may be transmitted to
the newborn. Using various data sources, we estimated that
nearly 850 congenital cases occurred in Argentina in 1993, or
6.3 expected cases per each reported case in 1994 and in
1994–2001. The congenital transmission of T. cruzi constitutes
a sizeable public health problem in the region. 
rypanosoma cruzi, the causative agent of Chagas disease,
infects 10–18 million people in the Americas (1), half of
whom most likely are women who may eventually transmit T.
cruzi to their newborns. As residual spraying of insecticides
against cone-nosed bugs (Triatoma infestans) and screening of
blood donors have produced a decreasing trend in human inci-
dence of Trypanosoma cruzi in Argentina, Bolivia, Brazil,
Chile, Paraguay, and Uruguay, the relative magnitude and visi-
bility of vertical transmission have been gradually emerging.
Congenital cases of T. cruzi are mostly asymptomatic or
monosymptomatic and seriously affect the newborn’s survival
and illness rate (2,3). Such cases cannot be prevented because
the available drugs have adverse effects, but early detection
and prompt treatment are frequently successful (3). However,
as screening of pregnant women and newborns has not been
routinely conducted in most T. cruzi–endemic countries, the
magnitude of the congenital transmission of this pathogen as a
public health problem has not been established. Having such
an estimate would be important for making policy recommen-
dations and health service planning. Our study estimates the
annual number of congenital Chagas cases that occurred in
Argentina recently and compares them with official case
reports. 
Materials and Methods
For a given province, year, and maternal age group, the
estimated number of live patients with congenital T. cruzi
infection was computed as the total number of live newborns
(f), times the probability of a woman’s being infected with T.
cruzi (p), times the probability of transmitting T. cruzi to the
live newborn (t). Province and age-specific numbers of live
births and maternal seroprevalence rates of infection are
needed to provide a countrywide annual estimate. 
The total number of live births in 1991 (694,776 new-
borns), according to the mother’s age group and province (4),
changed very little during the 1990s. We categorized births
uniformly within each maternal 5-year age class because data
on births of single-year age classes were not available; we did
not count the very small number of births in other countries or
with unspecified birthplace. 
The probability of a woman’s being infected with T. cruzi
varies with age; however, it may be estimated from the sero-
prevalence for T. cruzi in men of the same age group because
no evidence of a gender-related excess risk of infection has
been detected (5,6). For Argentina, the available province-spe-
cific seroprevalence rates of T. cruzi infection for young men
drafted into military service in 1965–1969 (when they were 21
years of age) and annually from 1981 to 1993 (when they were
18 years) showed quite different temporal trends  (7). Each
recruit age class was a randomly selected birth cohort;
unhealthy persons were excluded after blood samples were
taken. To reconstruct maternal seroprevalence rates in 1993,
we assumed a closed, steady-state population between year of
diagnosis and 1993. This assumption meant that a) the fraction
infected in each birth cohort remained stable because most T.
cruzi infections were acquired during childhood, and specific
treatment of infected adults was uncommon except for male
recruits and legal immigrants; and b) men and women ages
15–50 had similar age-specific death and emigration rates
because most findings of T. cruzi–specific pathology in
women occur at postreproductive ages (8). Potential differ-
ences in cohort-specific rates of recruitment or loss of infected
women through differential migration associated with T. cruzi
infection were ignored, although internal migrations may mod-
ify the expected number of cases, depending on the interplay
between fertility, T. cruzi infection, age at migration, and
source and destination of migrants. We ignored the contribu-
tion of increasing numbers of adult immigrants from neighbor-
ing T. cruzi–endemic countries since the 1950s. We tentatively
assumed that the chance of being pregnant and having an
uneventful pregnancy was not affected by infection with T.
cruzi, but present evidence is controversial.
The province-specific maternal prevalence of T. cruzi
infection in 1993 comprised the partial contributions of moth-
ers who were 18 years old in 1993 (born in 1975) and to whom
we assigned the seroprevalence rate of 18-year-old men
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assessed in 1993, and so on through mothers 30 years of age in
1993 (born in 1963) and to whom we assigned the seropreva-
lence rate of 18-year-old men assessed in 1981. For mothers
>30 years of age in 1993, we assigned the rate from 1965–
1969 data to 1967 and assumed that the prevalence followed a
linear trend between 1967 and 1981. The few 14- to 17-year-
old mothers were assigned the 18-year-olds’ seroprevalence
assessed in 1993. Tierra de Fuego was excluded from calcula-
tions because the time series had numerous missing data. Cal-
culations were carried out in an Excel spreadsheet, available
on request. 
The probability of congenital transmission from pregnant
women seropositive for T. cruzi has been extremely variable
(range 0.005–0.117) among countries and geographic areas
(1–3), and its determinants are little known (9,10). From the
latest review (3), we estimated the median t as 0.025 (inter-
quartile range 0.02–0.04). We assumed that t was not modified
by the mother’s age (9,10) because most mothers were in the
indeterminate or chronic phase of infection in which the para-
sitemia levels are low and age independent. We ignored poten-
tial geographic variations and parasite strain effects on t.
Results
The National System of Epidemiological Surveillance
reported (11) a total of 1,136 congenital cases of T. cruzi in
1994–2001 (annual mean 142; standard deviation 54), with no
significant time trend and very large asynchronic variations
among and within provinces (Figure 1). As demonstrated for
leishmaniasis surveillance in Argentina (12), inconsistencies
among provincial, national, and Chagas surveillance reports of
congenital cases were frequent and led to substantial underre-
porting.
A total of 846 congenital cases were estimated for 1993
(Figure 2A). An example of the calculations for the province
of Buenos Aires is given in the Appendix. The expected
annual number of congenital cases peaked in Chaco (153
cases) and the province of Buenos Aires (96 cases); the latter
had rare domiciliary triatomine infestations and a large num-
ber of immigrants from Chagas-endemic provinces during
1947 to the 1970s. Santiago del Estero, with high seropreva-
lence and fertility rates but very low human population, ranked
3rd (90 cases). The ratio between our conservative estimate of
congenital cases in 1993 (846 cases) and official notifications
in 1994 (135) and 1994–2001 (142 cases) was 6.3: 1. A very
rough calculation that used countrywide averages (f =
687,051; p = 0.019; t = 0.025) yielded 326 congenital cases, or
38% of the above estimate. 
Extreme differences between expected and reported mean
numbers of congenital cases occurred in Chaco and Santiago
del Estero, followed by Formosa, Tucuman, and Mendoza
(Figure 2A), suggesting strong underreporting. Santa Fe,
Jujuy, Salta, and the province of Buenos Aires reported most
cases. The ranked province-specific total numbers of cases
estimated for 1993 and reported officially from 1994 to 2001
were significantly correlated (Figure 2B) and thus provided a
qualitative hierarchic ordering of provinces in terms of the
likely burden of congenital cases. 
Additional calculations tend to support our rough esti-
mates. A pilot control program in a public maternity facility,
where 37.8% of all births in Tucuman took place, detected 32
congenital cases over 28 months (mean 13.7 cases per year)
(13). If we assume this was a random sample, the annual num-
ber of congenital cases projected to the whole province was
36.2 cases, which is roughly close to the expected number of
46.7 cases. 
Schmuñis (1) estimated that 1,593 congenital cases of T.
cruzi occurred annually in Argentina around 1985, on the
assumptions that the maternal seroprevalence equaled the
overall seroprevalence of T. cruzi in blood banks (6.96%); that
t = 0.03; and that no age-specific variations in fertility and
prevalence of infection occurred. When we used data on the
seroprevalence of T. cruzi among 131,909 pregnant women
(4.4%) from 15 Argentine provinces in 2000, and among
153,266 women (5.7%) from 20 provinces in 2001 (Sonia
Blanco, unpub. data), where f = 700,000 and t = 0.025, a simi-
lar calculation yields 770 and 997 estimated congenital cases
for 2000 and 2001, respectively. However, because mean rural
parity in 1991 was positively and significantly associated with
Figure 1. Nationwide and province-specific numbers of reported cases
of congenital Trypanosoma cruzi infection notified to the Ministry of
Health of Argentina. Mean coefficient of variation among provinces
over time, 266%; range 39% to 283%. For the city and Province of
Buenos Aires, we used the 1994–1999 data corrected by the Chagas
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T. cruzi seroprevalence in military recruits in 1993 at a prov-
ince level (Figure 2C), fertility and maternal infection also
may be positively associated at the individual level in rural set-
tings. Therefore, the use of average, province-wide fertility
rates would underestimate both the number of newborns from
infected women and the occurrence of congenital cases. 
Discussion
The congenital transmission of T. cruzi appears to be a
sizeable public health problem in Argentina, where it has
already surpassed the number of vector-mediated acute cases
by a factor of 10, and probably elsewhere in the region.
Despite a long-term decreasing trend in the human prevalence
of T. cruzi, for which we need increased prevention measures,
infected women of reproductive age will still give birth in the
foreseeable future. Available data favor a short-term policy of
antenatal diagnosis of pregnant women for T. cruzi infection
and follow-up of their newborns. Increased international
migrations from T. cruzi–endemic Latin American countries
suggest the need for an increased awareness among obstetri-
cians, neonatologists and pediatricians. Effective, nontoxic
drugs that may be administered to prospective mothers or
pregnant women to reduce the likelihood of congenital trans-
mission are clearly needed. 
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Appendix Table. Example of the calculations involved in the estimate of the number of congenital cases of Trypanosoma cruzi infection for the Province of Buenos 
Aires, 1993
Mother’s birth year Seroprevalence of T. cruzi  No. of live newborns No. of live newborns from infected women No. of expected congenital cases
1946 4.70 281   13.22   0.3
1947 4.57 281   12.85   0.3
1948 4.44 281   12.49   0.3
1949 4.31 1,322   56.99   1.4
1950 4.18 1,322   55.28   1.4
1951 4.05 1,322   53.57   1.3
1952 3.92   1,322   51.86   1.3
1953 3.79   1,322   50.15   1.3
1954 3.66   4,623 169.42   4.2
1955 3.54   4,623 163.44   4.1
1956 3.41   4,623 157.46   3.9
1957 3.28   4,623 151.47   3.8
1958 3.15   4,623 145.49   3.6
1959 3.02   8,628 260.37   6.5
1960 2.89   8,628 249.20   6.2
1961 2.76   8,628 238.04   6.0
1962 2.63   8,628 226.87   5.7
1963 2.50   8,628 215.70   5.4
1964 2.39 12,703 303.61   7.6
1965 2.31 12,703 293.44   7.3
1966 0.18 12,703   22.87   0.6
1967 0.15 12,703   19.05   0.5
1968 1.19 12,703 151.17   3.8
1969 1.04 12,571 130.74   3.3
1970 1.08 12,571 135.77   3.4
1971 0.77 12,571   96.80   2.4
1972 0.68 12,571   85.48   2.1
1973 0.65 12,571   81.71   2.0
1974 0.71   6,160   43.74   1.1
1975 0.70   6,160   43.12   1.1
1976 0.70   6,160   43.12   1.1
1977 0.70   6,160   43.12   1.1
1978 0.70   6,160   43.12   1.1
1979 0.70      695   4.86   0.1
Total 95.6
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